OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER

Clinical trial NCT01050114 · UNKNOWN

Trial details

NCT number: NCT01050114
Sponsor: Christopher Patrick Smith
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Overactive Bladder

Start date: 2013-08-01
Primary completion: 2018-07-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.